Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Large B-cell Lymphoma × Lymphoid × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 210 Precursor Cell Lymphoblastic Leukemia-Lymphoma 196 Leukemia, Lymphocytic, Chronic, B-Cell 171 Lymphoma, Non-Hodgkin 166 Lymphoma, Large B-Cell, Diffuse 158 Lymphoma, Follicular 151 Lymphoma, B-Cell 94 Lymphoma, Mantle-Cell 88 Recurrence 81 Burkitt Lymphoma 76 Leukemia, Myeloid, Acute 73 Leukemia 71 Hodgkin Disease 69 Lymphoma, B-Cell, Marginal Zone 66 Neoplasms 62 Multiple Myeloma 58 Hematologic Neoplasms 45 Myelodysplastic Syndromes 40 Waldenstrom Macroglobulinemia 37 Lymphoma, T-Cell, Peripheral 36 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 31 Lymphoma, T-Cell 27 Lymphoproliferative Disorders 25 Leukemia, Biphenotypic, Acute 25 Lymphoma, T-Cell, Cutaneous 24 Breast Neoplasms 21 Melanoma 19 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 19 Leukemia, B-Cell 19 Lymphoma, Large-Cell, Anaplastic 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07215585 2026-02-13

SOUNDTRACK-D2

AstraZeneca

Phase 3 Recruiting

Large B-cell Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡